Acompanhe as Notícias da Recifes

Os perigos ocultos dos peptídeos, e por que as mulheres correm maior risco Adobe Stock Uma onda de peptídeos não regulamentados está tomando conta do mundo do bem-estar, vendidos online com promessas ousadas sobre ganho muscular, antienvelhecimento e perda de gordura. Mas cresce

Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful. O recorte ajuda a contextualizar a pauta dentro de Tech.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and weight-loss management, but they have also led to some unfortunate outcomes. A recent study in JAMA Psychiatry has raised concerns that GLP-1 medications may

A wave of unregulated peptides is sweeping the wellness world, sold online with bold promises about muscle gain, anti-aging and fat loss. But concern is growing about side effects, and almost nobody is asking whether these substances affect men and women in the same way. The evid

Federal health scientists are urging caution about expanding access to controversial peptide drugs, even as the U.S. Food and Drug Administration (FDA) reshapes the advisory panel that will consider whether to loosen those restrictions.

For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with more meaningful reductions in hemoglobin A1C (HbA1c) levels than semaglutide, according to a study published online June 30 in the Annals of Internal Medi

Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly neighborhood influencer to the gym bros, injectable peptides have been all over social media and are now making mainstream news when things go horribly wrong.

To develop new and better peptides, the short amino acid strings behind medicines like GLP-1 drugs, researchers have used AI to generate candidates and to predict their properties.

A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a slightly higher risk of ischemic optic neuropathy (ION), a rare condition involving reduced blood flow to the optic nerve that can cause su

A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.

Committee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacyAdvisers to the Food and Drug Administration (FDA) will soon hold a meeting about whether to ease restrictions on access to some research peptides, a group of dr

Prof Channa Jayasena says growing online sales of unregulated drugs risk fatalities as responsibility falls between regulatorsFitness influencers linked to wellness brand helping run illegal steroid market on TelegramThe UK has become a “wild west” for people peddling experimenta